[go: up one dir, main page]
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Lawsuit challenges anti-ageing claims

Nature volume 488, page 18 (2012)Cite this article

Subjects

Former executive sues manufacturer of pill meant to rejuvenate cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jaskelioff, M. et al. Nature 469, 102–106 (2011).

    Article  ADS  CAS  Google Scholar 

  2. Bernardes de Jesus, B. et al. Aging Cell 10, 604–621 (2011).

    Article  CAS  Google Scholar 

  3. Harley, C. B. et al. Rejuvenation Res. 14, 45–56 (2011).

    Article  CAS  Google Scholar 

Download references

Authors
  1. Brendan Borrell
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Telomerase reverses ageing process 2010-Nov-28

Chromosome protection scoops Nobel 2009-Oct-05

Minimum telomere length defined for healthy cells 2007-Oct-03

Related external links

TA Sciences

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borrell, B. Lawsuit challenges anti-ageing claims. Nature 488, 18 (2012). https://doi.org/10.1038/488018a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/488018a

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research